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INTRODUCTION
Extramedullar solid tumors composed of partially differentiated hemato
poietic precursors have been variously described in the literature, with some
500 case reports since 1824 employing such terms as chloroma, chloroleukemia ,
and myeloblastoma. Early case reports (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11) took
particular note of the green color of many of the lesions, hence the term
chloroma, and the dramatic orbital involvement in children, sometimes producing
frog-like facies. Frequently however, these lesions lack distinctive coloration
so that Rappaport has suggested the more general term, granulocytic sarcoma (12).
Presently, this term is used to characterize invasive and destructive tumor masses
composed of immature cells of the myelomonocytic series.
Although for many years the lesions were associated with leukemia of various
cell types, presently they are understood to be an uncommon variant of acute
myelogenous leukemia, sometimes presenting before systemic involvement is detect
able. In these cases, a retrospective review of the pathologic interpretation^ )
reveals a wide spectrum of diagnoses, the most common misdiagnosis being histiocytic
lymphoma. Thus, although extramedull ary tumors of myeloid origin are thought to
be fairly rare, they present a difficult diagnostic challenge, particularly in
those cases in which definitive diagnosis may be of some therapeutic value. An
elevated index of suspicion would therefore be of value in certain clinical settings,
for example, the evaluation of proptosis in African children, where granulocytic
sarcoma ranks second to Burkitts lymphoma in incidence of orbital neoplasms.
Perhaps a full hematologic evaluation should also be performed in persons with
"lymphomatous" skin nodules of questionable nature, after consultation with an
experienced hematopathologist. Indeed, a component of the presumed rarity of
granulocytic sarcoma may correspond to a low degree of surveillance, a situation
which would merit correction, particularly as the possibilities for "prophylaxis"
2or early treatment of acute myelocytic leukemia become less debilitating and
the outcome more favorable.
The present study considers such diagnostic problems associated with granulo
cytic sarcoma in the context of eight cases presenting to Yale-New Haven Hospital
and its affiliated hospitals during the years 1976-1979.
31PATIENTS AND METHODS
The hematopathology files of Yale-New Haven Hospital were reviewed for cases
known to the Pathology Service during the past two years 1978-1979. These clinical
charts were reviewed, and follow-up information was obtained from the patient's
clinic chart and/or from the patient's physician directly. The Yale-New Haven
Hospital Tumor Registry was examined for coded cases of chloroma, chlorosarcoma,
leukosarcoma, lymphochloroma, and malignant neoplasms of the spleen and lymph
glands, with subsequent review of the charts of these suspected cases. The Tumor
Registry was also examined for coded cases of reticulum cell sarcoma (histiocytic
lymphoma), lymphosarcoma, giant follicular lymphoma, malignant reticulosis, and
reticuloendothel iosis associated with, or terminating in, acute myelocytic leukemia.
These charts were reviewed in an effort to detect cases of granulocytic sarcoma
which had been misdiagnosed. Similarly, the Tumor Registry of Danbury Hospital
was personally examined for coded cases of chloroma, chlorosarcoma, leukosarcoma,
lymphochloroma and malignant neoplasms of the spleen and lymph glands until 1975,
and for all cases of granulocytic sarcoma after 1975, with review of the charts of
all suspected cases. A collation of all such coded cases after 1975 on file at
the Connecticut State Tumor Registry was also performed. In addition, cases re
ferred to Yale-New Haven Hospital from Greenwich aHospital and Uncas-on-Thames
Hospital for pathologic consultation were fully reviewed, including interviews
with the patients and gross and microscopic examination of their lesions.
In each of the seven cases accepted for this study, a tumor was evident
clinically as well as pathologically. Each case also satisfied- at least two of
the following criteria: 1) the histopathologic picture was considered diagnostic
by an academic pathologist experienced in hematologic pathology, with convincing
evidence of granulocytic differentiation; 2) cytochemical stains for naphthol AS-D
4chloracetate esterase done on formalin-fixed, paraffin-embedded tissue sections
according to the procedure of Leder (13) revealed positive reactions in the cyto
plasm of undifferentiated or poorly differentiated neoplastic cells; 3) there was
hematologic evidence of granulocytic leukemia.
In three cases both hematologic confirmation and positive staining for
esterase activity supported the diagnosis; in two cases there were abnormal hema
tologic data possibly indicative of, but notdiagnostic for evolving leukemia in
addition to positive esterase activity. Biopsies from lesions in three of the
patients were positive for esterase activity in the absence of hematologic indication
of malignancy. One of these patients has expired, but for the remaining two patients,
efforts have been made to include current follow-up information in this report. A
final case is noted of a patient with acute myelocytic leukemia and multiple green
nodules over his trunk and lower extremities, although lack of histopathologic
evidence of granulocytic sarcoma precludes inclusion of this case within the series.
5CASE REPORTS
Case Report: A. A.
A. A., a 65-year-old white female, was admitted on 5/21/79 with an eight-
month history of melena and constipation, and a six-week history of constant
epigastric abdominal pain associated with bloating and nausea. Physical exam
revealed an abdominal mass 18 cm in diameter, extending from the epigastrium to
below the umbilicus. In addition, two 2 cm by 2 cm nontender, soft, mobile nodes
were present in the right posterior cervical chain, and a 1 cm by 1 cm soft node
was present in the right axilla. A spleen tip was 7 cm below the left costal
margin and the liver edge 12 cm from the right costal margin. Complete blood
count revealed Hct. 35.9 vol. %, Hgb 12.2 gm/dl , WBC 6,200 cells/mm3 with 50%
segs/17% bands/17% lymphs/ 11% monos/1% eo/4% blasts. The LDH was elevated to
4730 IU/dl . Upper GI barium study demonstrated the stomach to be compressed by
a large retroperitoneal mass. Anterior elevation of the pancreas and superior
mesenteric vein was evident by ultra sound. The liver-spleen scan showed splenomegaly
and a patchy hepatic uptake. Bone marrow aspirate revealed 80% blasts consistent
with acute myelocytic leukemia. Special staining showed 20% of the marrow cells to be
peroxidase positive, most blasts with a few granules positive to acid phosphatase,
but negative to PAS, and 20% of the immature forms positive to Sudan B. Alpha-
naphthol esterase Ttain was positive. The right cervical lymph node biopsy revealed
a diffuse infiltrate of immature cell forms consistent with involvement by acute
leukemia, myelomonocytic type. IgM Ab with mixed < and x light chains were present
on the surface of the neoplastic cells. On the 18th hospital day the patient became
febrile, hypotensive and died of acute posterior wall myocardial infarction.
Post-mortem examination revealed tumor infiltration of the cervical, para-aortic,
and inguinal lymph nodes, pancreas, and kidneys bilaterally, in addition to the
large midline retroperitoneal mass lesion.
6Comment: /\. f\
In this patient, abdominal symptomatology resulting from extensive
extra-myelogenous involvement of the retroperitoneum preceded by 8 months
the diagnosis of acute myelomonocytic leukemia. It is significant that
biopsy of a soft, mobile posterior cervical node revealed infiltration
by primitive hematopoietic cells. In light of the prognosis of untreated
AMML, it is likely that this patient's tumor masses preceded bone marrow
evidence of leukemia by a number of months. The patient died approximately
3 weeks after diagnosis, approximately 9 months after the onset of symptoms
referable to granulocytic sarcoma.
Case Report: L. M.
L. M., is a 72 year-old white female who for the preceding year had
experienced pain in the lower back and in the right anterior femoral area.
On 2/20/79 she had low-grade fever, and was found to have several immature
granulocytic cells on peripheral blood smear. Her last blood count was in
4/78. Physical examination was remarkable only for obesity and slight in
duration of the right thigh. Complete blood count showed Hct. 39.2 vol. %,
Hgb. 13.2 gm/dl, WBC 12,500 cells/mm3 with 19% segs, 27% bands, 19% lymphs,
18% monos, 3% myelos, 3% metas, 5% atyp lymphs and 6% blasts. The bone marrow
biopsy was consistent with a hematopoietic neoplasm manifesting predominantly
erythroid differentiation. The blasts cells were negative for four stains.
Intermediate forms were positive to sudan B, peroxidase, and alph-naphthol
esterase. Aspirate suggested acute myelocytic leukemia, with 53% blasts.
7By 3/15/79, physical examination revealed an ill -defined soft tissue
mass in the mid-portion of the right thigh. The left calf was also tender
with an ill-defined mass, the circumference being 6 cm greater than the
right side. In addition, multiple 1 cm nontender subcutaneous lesions
were noted on the anterior abdominal wall of the left upper quadrant. In
creased gallium uptake in the soft tissues of the right thigh, left calf,
and also the left lateral thigh was present. Biopsy of the left calf de
monstrated involvement by acute non-lymphoid leukemia; results of esterase
staining are presently unavailable.
The patient subsequently received 1800 Rads to the right thigh, and 1800
Rads to the left calf, which resulted in total regression of the lesions.
Peripheral smear at that time however, showed 21% blasts. In accordance
with her wishes, aggressive systemic chemotherapy was not initiated. She
expired on 5/9/79 and a post-mortem examination was not permitted.
Comment: L. M.
In this patient, symptomatology possibly referable to extramyelogenous
involvement by primitive hematopoietic cells preceded apparent systemic in
volvement by approximately two years. As the offending lesions were not as
well-defined as in other cases, gallium scan served well in localizing them,
supporting its general use in the detection of tumor masses in leukemic
patients (14). This patient expired almost 10 weeks after definitive diagnosis,
approximately 27 months after the onset of symptoms possibly referable to
granulocytic sarcoma.
8Case Report: I. B.
I. B., a 77 year-old white male, noted an enlarging right cervical
mass over a six month period, with associated weight loss. On admission
in 12/78, physical exam revealed a firm, nonmobile right cervical mass mea
suring 15 by 9 by 15 cm. Histology was initially interpreted as poorly
differentiated carcinoma and further workup, including brain scan, liver-
spleen scan, intravenous pyelogram, bone scan, lung tomography, barium
enema, sinus films, and C-spine films were normal. Complete blood count was
within normal limits, and a bone marrow examination was not performed. The
patient was treated with 5,600 Rads to the neck mass, with an excellent result.
On further evaluation of the patient's surgical specimen, the diagnosis
of granulocytic sarcoma was established, and he was re-admitted on 3/6/79.
Physical examination was significant for two masses in the right posterior
triangle, one measuring 1 by 1 cm, the other being 2^ by 2% cm. Biopsy was
consistent with granulocytic sarcoma, with positive staining to Giemsa and
alpha-naphthol esterase. Complete blood count showed Hct 36.2 Vol. %, WBC
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5,100 cells/mm with 73% segs, 9% bands, 2% lymphs, 13% monos, and&3% eos.
Bone marrow biopsy revealed an abnormal hypercellular marrow with sideroblastic
hematopoiesis and marked relative increase in immature granulocytes, suspicious
for evolving leukemia.
Although no significant adenopathy had been noted on 3/6/79, by 3/20
the patient had developed firm, 3 by 3 cm, non-tender, bilateral axillary
masses. By 3/23 the masses had evolved markedly, and now included a sub
mental mass measuring 5 by 5 cm. Extensive mediastinal adenopathy, partially
compressing the trachea was seen on chest x-ray. Emergency radiotherapy was
initiated, with a final total dosage of 2,000 Rads to the submental region,
91400 Rads to the mediastinum and lung parenchyma. The patient also received
a ten-day course of Hydroxyurea. The masses continued to enlarge, and by
3/31/79 the tumor masses appeared to be completely refractory to therapy,
resulting in the patient's death on 4/8/79.
Post-mortem examination revealed a firm, nonmobile right anterior neck
mass 10 by 6 cm, bilateral axillary masses 8 by 6 cm and 4 by 3 cm, infiltrating
lesions of the omentum and peritoneal surface, and involvement of the liver,
small intestins (5 cm diameter transmural mass), as well as the hilar, esophageal,
peripancreatic, and para-aortic lymph nodes.
Comment: I. B.
The dramatic course of this patient exhibits the possible extensive,
non-remitting nature of peripheral involvement by primitive hematopoietic
cells. The initial presentation ocurred approximately 9 months before
an abnormality was detected on bone marrow examination, which was suspicious
but not diagnostic for leukemia. At no time was evidence of a leukemic
change observed in the peripheral smear, even up to the time of death, which
ocurred approximately 4 weeks after diagnosis, ten months after the initial
manifestation of a mass lesion.
Case Report: M. G.
M. G., a 69 year-old white female, developed a red, swollen right eyelid
about Zh weeks prior to admission, with subsequent development of diplopia.
A biopsy of the right orbital mass revealed granulocytic sarcoma, which stained
positive with alpha-naphthol esterase. On 8/31/79, physical examination was
significant for a rock-hard, infiltraying lesion of the right upper lid, filling
the entire superior orbit, displacing the globe 3-4 mm; the lesion was fixed
10
to the periosteum. Complete blood count revealed Hct. 36.5 vol. %, Hgb.
12.3 gm/dl, WBC 6,000 cells/mm3 with differential of 72% segs, 2% bands,
15% lymphs, 8 monos, 1% eo and 1% baso. Bone marrow showed no evidence of
acute leukemia. A CT scan disclosed no evidence of extension into the
optic chiasm or the brain. The remainder of her workup was unremarkable
and included a liver-spleen scan, bone scan, sinus films and a gallium
scan.
As a consequence of the rapidly developing right lateral gaze im
pairment, immediate radiotherapy and steroid therapy was administered, yielding a
marked reduction of proptosis after three days. The patient received a
total of 2600 rads by en face portal to the right orbit, but without
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complete resolution of the lesion. At that time WBC was 7,800 cells/mm
with a normal differential.
In 9/79, the patient noted a right pre-auricular mass and associated
cervical lymphadenopathy, with the bone marrow having increased
although the changes were not diagnostic of leukemia. Peripheral smear at
that time was normal. Systemic chemotherapy was begun according to the CH0P-
Bleomycin protocol, with partial remission of the lesions. The patient was
re-admitted in 1/80 complaining of malaise and weakness, with 90% blasts
in her peripheral smear. Bone marrow biopsy was consistent with acute myelo
cytic leukemia, and systemic chemotherapy was begun with Daunorubicin-
Thioguanine-Ara-C.
Comment: M. G.
This patient presented with orbital involvement causing proptosis,
long recognized as a classical clinical feature of granulocytic sarcoma
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as a consequence of its predilection for development in the periosteum
of the skull (15, 16, 17, 18). Initially, her disease was distinctly
ophthalmologic, controlled by radiation therapy with no evidence of
systemic spread until approximately 4 months after her initial sympto-
mology. This is consistent with the 1 iterature which indicates likely
onset of acute leukemia within 10 months, although in one case a period of
36 months passed before systemic involvement was manifest (19).
Case Report: C. C.
C. C. , a 58 year-old white male, was in good health until about two
months prior to admission, when he developed retropubic and lower abdominal
pain of increasing intensity, with subsequent bright red blood per rectum.
Physical examination in 9/78 was remarkable only for a tender LLQ mass.
Complete blood count was within normal limits. Barium enema localized the
mass to the rectosigmoid junction. The patient responded well to antibiotic
therapy for the presumed diagnosis of ruptured diverticulum.
The patient did well for two months, then developed progressive rectal
and perirectal pain associated with a pressure sensation. A barium enema
demonstrated an ulcerated rectosigmoid mass. At laparotomy, an unresect
able rectal tumor was discovered which was infiltrating the pelvic wall; two
additional jejunal mass lesions were also present. Microscopic examination
initially was felt to indicate multiple nodules of malignant tumor with a
plasmacytoid appearance, infiltrating large blood vessels, pericolic and
mesenteric fat; positive to methyl green pyrimine stain. Final diagnosis:
malignant lymphoma, lymphomplasmocytic, diffuse, with 1 of 11 lymph nodes
positive.
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A second opinion favored "involvement by primitive hematopoietic or
lymphoid neoplasm; favor myelomonocytic leukemic infiltrate over other
possibilities". Bone marrow was normocellular, with normal myelopoiesis
but with "focal aggregates of young lymphocytes, plasmoid lymphocytes,
plasma cells and lymphoblasts ; suggestive of lymphoprol iferative disorder
involvement".
CBC was again within normal limits. The patient underwent six cycles
of Cytoxan, Adriamycin, Oncovin, Prednisone and was re-admitted after two
months with chief complaint of lower back pain. CBC was again within normal
limits. Liver-spleen scan and bone scan were negative, but abdominal CT
scan revealed grossly enlarged retroperitoneal, mesenteric, and right iliac
nodes. 1260 Rads were administered to the abdomen over the following two
weeks, but he developed increasing weakness, lethargy, dyspnea, and fever.
A chest film demonstrated the presence of a diffuse interstitial pattern
and prominent right paratracheal adenopathy. Antibiotic therapy was instituted,
as well as a course of Adriamycin, Bleomycin, Velban, and DTIC without
objective response. He succumbed to an undiagnosed pneumonia on 8/17/79.
CBC at the time of death was: Hct. 33.3 vol. %, Hgb. 11.2 gm/dl , WBC 4,000
cells/mm with a differential of 39% segs, 49% bands, 10% lymphs and 2% monos.
A post-mortem examination was not permitted.
Comment: C. C.
This patient's diagnosis was shrouded in controversy, with the initial
interpretation of the surgical specimens from the ileum and colon being mali
gnant lymphoma with plasmacytoid appearance; consultation favored myelomono
cytic leukemic infiltrate, although bone marrow and CSF examination appeared
consistent with a lymphoprol iferative process.
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In this regard it is worthy of note that histiocytic lymphoma has
been shown to develop a leukemic phase (20, 21, 22) and also that there
has been considerable difficulty in the literature in the differentiation
of the leukemic transformation of histiocytic lymphoma from granulocytic
sarcoma (9, 23, 24).
The patient was without bone marrow or peripheral smear evidence of
acute leukemia through the time of his death, approximately 8 months after
laparatomy, approximately 12 months after the development of symptoms re
ferable to the retroperitoneal lesion.
Case Report: H. W.
H. W., a 58 year-old white female, was well until 12/77 when she noted
a rapidly enlarging, non-tender mass on the left side of her back. The biopsy
revealed an undifferentiated tumor with likely possibilities being melanoma,
sarcoma, or histiocytic lymphoma. Melanin stains were negative. In 3/77
she was admitted with several hard subcutaneous masses measuring from 1 to
2.5 cm in diameter overlying the chest, back, right shoulder and arm, and
right lower abdominal wall. Immature cells were not seen on a blood smear.
Liver-spleen scan, barium enema, intravenous pyelogram, bone scan, sigmoido
scopy and chest film were normal. The patient was referred to Uncas-on-Thames
Chemotherapy Clinic on 3/9/78 for therapy because of rapid enlargement of her
skin nodules. New lesions were also present on the legs and a new node in the
left axilla was 5 by 3 cm. A repeat CBC did not show leukemia, and bone marrow
studies were normal .
The patient was not treated because of pneumonitis. She was re-admitted
4/26/78 with further progression in size and number of the nodules (smallest
0.3 cm, largest 7 cm dia.) which were without discoloration. She was begun
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on cyclophosphamide, vincristine and prednisone chemotherapy which resulted
in a dramatic decrease of all nodules. By 5/9/78 all the skin nodules had
disappeared. The patient subsequently did well on q 3 week courses of cyclo
phosphamide, vincristine and prednisone chemotherapy (CVP), with minor re
currence of few small (0.5 to 1 cm) nodules in the mid-scapular and peri
umbilical areas.
Chemotherapy was discontinued after 7 courses because of chronic bronchitis.
During this period enlargement of left and right paravertebral nodules to
2 by 2 cm occurred. During the subsequent 6 courses of CVP (total of 13)
these masses did not remit, and on 3/14/79 a 4 by 3 cm mass on the right
posterior trunk was noted to be rapidly growing, the biopsy of which was a
malignant neoplasm with cytologic features consistent with a monocytoid
neoplasm; (granulocytic sarcoma). The Alpha-naphthol esterase stain was
positive.
During the following two weeks the mass increased in size to 12 by 13 cm,
and the bone marrow had increased numbers of immature granulocytes (M:E of
5:1) and a predominance of sideroblastic megaloblastoid elements. This was
not diagnostic for leukemia, although a few immature forms had been observed
in selected peripheral smears. On 4/11/79 the patient received her fourteenth
cycle of CVP which resulted in a reduction of the right posterior trunk mass
to 6 by 9 cm. This mass however, increased to 18 by 15 cm over the following
three months in spite of therapy, and hepatosplenomegaly was documented by
liver-spleen scan. Repeat marrow examination on 7/31/79 demonstrated a pre
dominance of sideroblastic megaloblastoid elements; not diagnostic for
leukemia (while there is atypia of cell lines and increased immature cells,
maturation is present in all cell lines and blast forms are neither sufficiently
15
numerous nor clustered to permit the diagnosis of leukemia). The blood
smear was still normal on 9/7/79
The patient completed a course of 1350 Rads to the right posterior
trunk lesion on 8/13/79, and was admitted for re-evaluation on 9/79 as a
consequence of progressive weakness. At that time, chest x-ray showed
multiple enlarged pulmonary nodules and bone marrow again revealed ringed
sideroblasts, but not diagnostic for leukemia. Chemotherapy with Bleomycin,
Adriamycin, Cytoxan, Vincristine and Prednisone was administered, with
significant partial remission of the lesions.
Comment: H. W.
This patient has survived 26 months since the initial manifestation
of a mass lesion, and diagnosis of granulocytic sarcoma. She was initially
responsive to CVP, but became refractory and presently is responding to BACOP
therapy. The bone marrow has an increase in the relative numbers of immature
granulocytes, although the peripheral smear has been non-diagnostic. It will
be instructive to follow the treatment course of this patient in parallel with
that of J. S.
Case Report: J. S.
J. S., a 44 year-old white male, was well until 5/79, when he developed
a continuously enlarging mass in the left axilla. On admission on 6/7/79,
this mass was 8 cm in diameter, multiple similar nodules were present on the
anterior and posterior thorax, and over the arms and legs. The WBC was 7,100
cells/mm with 66% segs, 2% bands, 30% lymphs and 1% mono. Biopsy of the left
axillary mass and subcutaneous tissue of the chest wall was initially interpreted
as malignant lymphoma, diffuse, non-Hodgkin 's, with mixed cellularity. Review
of the right chest wall biopsy by a third consultant favored involvement by a
16
primitive malignant mesenchymal neoplasm, with features more suggestive
of granulocytic sarcoma than lymphoma.
By 7/5/79, the patient was noted to have more than 35 mobile, non-tender,
firm subcutaneous nodules over his trunk and legs, ranging from 1 to 8 cm in
diameter, some with a blue hue. Repeat biopsy of the right forearm revealed
granulocytic sarcoma, with electron microscopy findings consistent with a
primitive hematopoietic neoplasm of promyelocytic origin. Alph-naphthol
esterase stain was positive. Bone marrow studies on 7/13 showed partially
megaloblastic erythroid hyperplasia, with left shift in myeloid maturation
consistent with an early myeloproliferative disorder.
A lesion was demonstrated at the base of the third ventricle by CT
scan. Abnormal retroperitoneal and lift iliac nodes were visualized on the
lymphangiogram. The intravenous pyelogram (IVP) demonstrated the kidneys to
be enlarged, but the renal function normal. Lung tomography and chromosomal
studies were normal .
Beginning on 7/7/79, the patient was treated with Decadron which resulted
in an 80% regression of the lesions within three days. Subsequently, he was
placed on the ACOMA protocol (Adriamycin, Cytoxan, Vincristine, followed by
eight weekly courses of Methotrexate (with Leucovorin rescue) and Ara-C) with
total disappearance of all lesions, including the previously noted brain lesion.
Presently, the patient has received 1 course of Adriamycin, Cytoxan, and Vin
cristine and 7 courses of Methotrexate and Ara-C, with continued complete
remission of subcutaneous disease, and without leukemic changes on peripheral
smear-
17
Comment: J. S.
This patient exhibits many similarities to H. W., with both apparently
developing a single enlarging mass, then multiple masses over the trunk and
legs. Both patients received steriods with dramatic response, in addition
to Cytoxan and Vincristine, with J. S. also receiving Adriamycin, MTX,
and Ara-C. Presently J. S. is doing well approximately 30 weeks since the
initial manifestation of his lesions, with no evidence of systemic involve
ment.
Case Report: R. M.
R. M., a 71 year-old white male retired nuclear reactor technician,
was well until seven months prior to admission when he developed severe
arthralgias in both knees and ankles, with simultaneous slow growth of
multiple skin nodules over his trunk and legs. Arthrocentesis was non
diagnostic, skin biopsy was not performed, and the patient was treated with
oral steroids which resulted in symptomatic relief and a temporary remittance
of the lesions.
After seven months, the patient was re-hospitalized with progressive
weakness, loss of apetite, and 10-pound weight loss. On 7/13/76, physical
examination was significant for multiple green nodules over the anterior
and posterior trunk, multiple palpable nodules on the legs, some with a
purple hue, and a 6 cm by 4 cm tender, firm left testicular swelling. The
complete blood count was: Hct. 22.8 vol %, Hgb. 7.5 gm/dl, WBC 216,700 cells/mm'
with a differential of 2% segs, 1% myelocyte and 97% blasts; the platelet
3
count was 19,000/mm . The blasts cells were peroxidase positive. Bone marrow
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aspirate was consistent with acute myelomonocytic leukemia.
The patient was treated with leukapheresis,whole brain irradiation,
Methotrexate with Leucovorin rescue, and two seven-day courses of cytosine
arabinoside. Some diminution in size of the lesions was noted after two
courses of leukapheresis and Methotrexate. A dramatic response followed
the cytosine arabinoside therapy. A pulmonary infection developed however,
which was refractory to medical therapy and the patient expired seven weeks
after admission. Post-mortem examination was not permitted.
Comment: R. M.
In this patient, noticeable involvement of the skin by green nodules
preceded the diagnosis of AMML by 7 months, with some remittance of the
lesions on oral steroids during that period. It is possible that this severe
knee and ankle arthralgias were a consequence of intra-articular tumor
invasion, with symptomatic relief secondary to the cytolytic effect of the
steroid therapy. Subsequently the lesions progressed, with development of
systemic symptoms, and dramatic shrinkage of the skin nodules following two
courses of Methotrexate and leukapheresis. It must be noted that at no
time during this patient's hospital course was skin biopsy performed, so
that results of alpha-naphthol esterase stain are unavailable. Death occurred
within one month of diagnosis, approximately 8 months after the presumed
appearance of granulocytic sarcoma.
RESULTS
Review of the Connecticut State Tumor Registry revealed approximately
170 cases of acute myelocytic leukemia during 1978-1979, with no reported
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cases classified as granulocytic sarcoma within this group. The 5 cases
admitted to Yale-New Haven Hospital were evaluated during a 2-year period
during which 54 new adult cases of acute non-lymphoid leukemia were also
seen (9.2%). This denominator does not include smouldering leukemia,
leukemic complications of chemotherapy, or blastic transformation of known
myeloproliferative syndromes. Given the visceral infiltration characterizing
many of these lesions, this incidence is expected to be lower than the in
cidence in autopsy series, which report tumor formation variably in 3% (26)
to 8% (27) to 35% (28) of patients with leukemia. In five of the cases
presently considered, the diagnosis of granulocytic sarcoma was made in the
absence of bone marrow evidence of acute leukemia. In 4 of these instances
this diagnosis differed from the initial interpretation which was poorly
differentiated carcinoma in two cases, and malignant lymphoma in two cases.
The seven patients ranged in age from 44 to 77 years, with a median
age of 64 years. It must be noted that this series included only adult
patients, so that these data do not necessarily conflict with the autopsy
series of Liu (27), which reported a significantly higher incidence of
granulocytic sarcoma in patients less than fifteen years of age, with none
of 23 cases occurring in a patient above 60 years of age. No particular
gender predominance is evident in this small series.
As noted in table 1, the clinical picture at the onset of disease
varied considerably as a consequence of the insidious development and re
latively non-discriminating anatomical infiltration of the lesions. The
presenting signs and symptoms were generally similar to those reported in
the previously mentioned autopsy series, with pain (4/7) and tumor nodules
(5/7) being most common. Motor disturbances, reported in approximately
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one-half of Liu's series, were uncommon in these patients.
For those patients in whom the diagnosis of granulocytic sarcoma was
initially made in the absence of leukemia, the length of time between
the diagnosis of local and systemic disease varied from 3 months to an
undetermined time span for the patients thus far without definite evidence
of leukemia (presently up to 22 months). In the literature, the longest
reported leukemia-free interval is approximately three years (19).
The patients in this series all had multiple tumors, with involvement
of more than one type of tissue. Aggressiveness of the disease could not
be distinctly correlated with anatomical site of involvement. The survival
time after diagnosis for the three patients with acute myelogenous leukemia
not treated systemically varied from 3 weeks to 10 weeks, somewhat shorter
than the expected survival time for patients with acute myelocytic leukemia
without distinct localized involvement (2 to 3 months (29), however the pre
sent data base is insufficient for significant conclusions. Previous reports
(30) which indicate that the survival time of patients with acute myelocytic
leukemia and solid tumor formation is generally similar to that of patients
without solid tumor formation. One patient diagnosed with acute myelocytic
leukemia is presently undergoing systemic chemotherapy.
Empirical use of diffuse histiocytic lymphoma protocols for the two
surviving patients without definite bone marrow evidence of leukemia is
based upon the responsiveness of the lesions and the relatively benign
nature of this therapy. Thus far neither patient has transformed to classic
leukemia, yet clearly the issue of treatment for these patients must be
reviewed in an effort to optimize the use of chemotherapeutic agents.
Only one case is reported of "intensive treatment" of leukemia initiated in
light of the diagnosis of granulocytic sarcoma, without hematologic evidence
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of systemic disease (15). This patient was reported to survive for over
three years, however the details regarding the type of leukemia, extent
of disease, and nature of therapy are not described.
TABLE 1
CLINICAL FINDINGS AT TIME OF BIOPSY/SEVEN PATIENTS WITH GRANULOCYTIC SARCOMA
I. B.
C. C,
Age/
Sex
77/M
58/ F
65/F
72/F
69/F
44/M
58/M
Presenting Signs/
Symptoms
Mass Lesion,
Anorexia, Wt. Loss
Mass Lesion
Site/
Lesion(s)
R/Cervical
L/Flank
Bone
Melena, Constipation R/Cervical
Abdominal Pain
Leg Pain, Back Pain
Mass Lesion,
Diplopia
Mass Lesions
Abdominal Pain
Bright Red Blood Per
Rectum
R/Thigh,
L/Calf
R/Orbit
L/Axil la
Rectos ignmo id
Lymphadenopathy Splenomegaly Hgb. WBC Differential Marrow
None
Bilateral Axil
None
None
Contralateral
Cervical
None
None
Ipsilateral Axil. None
7 cm
None
None
None
None
12.6 5,100 Normal Not preform
ed (Abnormal
2 month
Subsequently]
12.2 16,200 78P/15L/ Initially
7M Normal Abnor
mal 1 month sub
sequent.
12.2 6,200 4% Myelo- 80%
blasts blasts
13.2 12,500 6% Myelo- 53%
blasts blasts
12.3 6,000
14.0 7,100
Normal Without
Evidence of
Leukemia
Normal Without
Evidence of
Leukemia
12.5 8,600 Normal Abnormal
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TABLE 2
SUMMARY OF PATHOLOGIC FINDINGS/SEVEN PATIENTS WITH GRANULOCYTIC SARCOMA
Chloracetate
Patient
Site/
Lesion(s)
I. B. R/Cervical
Initial
Diagnosis
Carcinoma
Subsequent Bone Involvement At Esterase Other
Diagnosis Marrow Autopsy Activity Pathology
Granulocytic Suspicious For Bilateral Cervical * (+) R/Cervical Malabsorption
2° to BowelSarcoma Evolving Leuk Axillary Hilar, Mass
emia Para-aortic nodes, Involvement
Transmural Involvement
of small intestine,
Diffuse involvement of
Bowel serosa, Peritoneum
& Omentum
H. W. L/Flank
coma vs.
Poorly Differentiated Granulocytic Abnormal, with
Tumor; melanoma vs. sar- Sarcoma Predominance of
histiocytic EM: Consistent Sideroblastic
Lymphoma With Mejaloblastoid
Monocytoid elements; not
Neoplasm Diagnostic of
Leukemia.
(+) R/Flank Multiple
Pulmonary Nodules.
Hepatospl enomagal^
Massive Bony Up
take.
A. A. R/Cervical INVOLVED BY AMML 80% Blasts c/w AMML Cervical, (+) R/Cervical IqM antibody
Injuinal , Para-aortic
nodes, pancreas, spleen,
kidneys.
Mass with mixed k &X
1 ight chains pre
sent on surface of
neoplastic cells
(likely, host-de
rived antitumor abl
L. M.
M. G.
L/Calf
R/Orbit
- INVOLVED IN ACUTE NON-LYMPHOID LEUKEMIA -
53% Blasts
- PRIMITIVE SMALL CELL NEOPLASTIC INFILTRATE -
MOST C/W ACUTE NON-LYMPHOID LEUKEMIA
Initially Without
Detectable Involvement By
Subsequently, C/W AML
(+) R/Orbital
Mass
(+) R/Pre-Auricular Mass
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TABLE 2
Continued
SUMMARY OF PATHOLOGIC FINDINGS/SEVEN PATIENTS WITH GRANULOCYTIC SARCOMA
Chloracetate
Initial Subsequent Bone Involvement At Esterase
Diagnosis Diagnosis Marrow AutoPSy Activity
Other
Pathology
Malignant Lymphoma Granulocytic Mild Increase in
Non-Hodgkin's, Mixed Sarcoma Immature Myeloids;
Cellularity Not Diagnostic of In
volvement by Tumor.
(+) R/Forearm Multiple (>30)
Subcutaneous Noc
ules, contrast
enhancing, lesion
in area of third
Ventricle.
d Malignant Lymphoma Favor Granulo- Abnormal
Lymphoplasmocytic cytic sarcoma
Jejunal mass
lesions, R/para-
tracheal , mesen
teric nodes.
SIADH
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TABLE 3
GRANULOCYTIC SARCOMA DIAGNOSED IN THE ABSENCE OF LEUKEMIA
Patient
H. W.
M. G.
J. S.
C. C.
Signs & Symptoms Relating Time From Onset/ Time From Onset/ Evidence
To Localized Symptoms of Diagnosis Symptoms of Diagnosis Inducing Treat-
Tumor Mass of Granulocytic Sarcoma of Acute Leukemia Leukemia ment Response
Survival
after
Diagnosis of
Leukemia
Mass Lesion, Anorexia,
Weight Loss
Mass Lesion
Mass Lesion, Diplopia
Mass Lesions
Abdominal Pain, Bright Red
Blood Per Rectum.
8 Months
16 Months
1 Month
1 Month
8 Months
9 Months
>23 Months
4 Months
No Diagnosis Made
No Diagnosis Made
BM: Hypercellular! 7400 CR, then NR 3 weeks
increased no
of immature
granulocytic
C/W pre-leukemic
state.
Rads
to submental
region, chest,
PB: Normal
BM: Abnormal, but 11300 Rads
not diagnostic to PR
of leukemia, [trunk
CVP chemo Rx.
BACOP chemo Rx.
PB: Normal
BM: C/W AML 2600 Rads PR
to R/orbit. CHOP
Bleo protocol -
DAT protocol .
PB: 90% Blasts
AC0MA DHL Protocol
CR
1260 Rads be-PR
low diaphragm, C0AP
Chemo Rx.
** Key_
CR - Complete Response, PR - Partial Response, NR - No Response, BM - Bone Marrow, PB - Peripheral Blood
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CLINICOPATHOLOGIC OBSERVATIONS
Extramedullar myeloid tumors are commonly composed of relatively uniform,
poorly differentiated cells with irregular nuclei and scanty to moderate amounts
of cytoplasm. Although the defining characteristics of the tumor cells are
exactly those of peripheral leukemic cells, they are often not readily recog
nizable on routine hematoxylin and eosin stained sections, as a consequence
of minimal granulocytic differentiation. Rappaport (12) maintains that a
definitive diagnosis of granulocytic sarcoma must be based on the identification
of such immature myeloid elements in the blood and bone marrow. Consequently,
cases in which myeloid tumors precede systemic evidence of granulocytic
leukemia, sometimes by one to two years, present a potentially difficult diag
nostic problem.
Of particular note is the marked histologic similarity on routine section
between granulocytic sarcoma and histiocytic lymphoma, and the dearth of objective
morphologic criteria for their distinction. Zimmerman and Font (15) record the
diagnostic confusion in a review of eighteen cases of granulocytic sarcoma of the
orbit, noting that eleven of the original pathologic diagnoses were malignant
lymphoma, eight of these being histiocytic lymphoma. Other misdiagnoses included
rhabdomyosarcoma, neuroblastoma, Ewings sarcoma, and eosinophilic granuloma. Thus,
a neoplasm of hematopoietic elements may masquerade as any of a fairly wide
variety of lesions (31), possibly contributing to the presumed rarity of this
presentation.
In this context it is interesting to review reports of histiocytic lymphoma
subsequently associated with, or terminating in acute myelocytic leukemia. This
phenomenon is well documented (20, 21, 22, 32, 33, 34) although fairly uncommon
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and poorly understood. The literature reveals many attempts at an explanation (35),
including possible dissemination secondary to vascular invasion, leukemoid response
to preterminal infection and possible toxicity of radiation and chemotherapy. In
addition, the pluripotentiality of primitive cellular elements has been frequently
invoked. Indeed, it has been suggested that histiocytic lymphoma, granulocytic
sarcoma, and acute myelocytic leukemia may be variants of the same disease (36).
It is possible however, that in a significant percentage of these cases early extra-
medullary indicators of leukemic involvement may have been missed in the diagnosis
of histiocytic lymphoma.
In a discussion of four cases of leukemic transformation of histiocytic
lymphoma, Lowenbraun and co-workers (20) note four clinical characteristics to
be more diagnostic of histiocytic lymphoma transformation than of myeloblastoma:
1) relatively long duration (four months, one year) from diagnosis to transformation,
2) atypical CNS involvement, 3) rapidly fulminating course refractory to chemo
therapy after the "leukemic change" has occurred, and 4) nodal disease. Review of
the literature and the cases under present scrutiny does not strongly support the
use of the first three criteria. In addition, nodal involvement clearly is not an
uncommon finding in patients with granulocytic sarcoma. Indeed, histiocytic
lymphoma has been reported (39) to develop in the course of otherwise typical
myeloid leukemia. Possibly these lesions correspond to "extrameduUary blast crises"
rather than true lymphoma, and precede blastic changes in the blood and bone marrow.
It becomes clear then, that data gleaned from routine clinical and cytomorpho-
logical (38) evaluation often provide little insight into the nature of lesions
ultimately known to be granulocytic sarcoma. A brief discussion of some of the more
specialized diagnostic maneuvers will follow.
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DIAGNOSTIC TOOLS
Cytochemistry
The use of specialized cytochemical stains (39) has clearly proven most
fruitful in defining diagnostic possibilities. In particular, the Giemsa and
PAS stains have been useful for demonstrating eosinophilic and other granulocytic
precursors. Recently, the immunoperoxidase stain for intracellular lysozyme
has been considered (40), taking advantage of the fact that the majority of
so-called "histiocytic lymphomas" are derived from transformed lymphocytes. This
technique is limited by the fact that cells involved with malignant histiocytosis
will stain positively. In addition, since lysozyme in found in primary granules,
it appears first at the promonocyte stage, so that earlier forms remain unidentified.
Most importantly, the chloracetate stain done according to the method of
Leder (13) is essential for confirming granulocytic origin and distinguishing
a specimen from histiocytic lymphoma. Cytoplasmic esterase activity is strongest in
mature neutrophilic granulocytes, promyelocytes, myeloblasts, and mast cells, dem
onstrated by reddish-brown intracytoplasmic aggregates on formalin-fixed, paraffin-
embedded sections of tumor. Activity is absent or questionable in lymphocytes,
plasma cells, macrophages, monocytes, erythroblasts, megakaryocytes and eosinophilic
and basophilic granulocytes. In contrast, macrophages demonstrate activity to non
specific esterase, which is not present in granulocytes or their precursors. There
fore, esterase stains should provide for positive differentiation between tumors of
granulocytic and lymphocytic origin (41, 42, 43, 44). Valid results depend on
the availability of wet tissue or paraffin-embedded material that has been
well -fixed in formalin. These stains have been performed successfully on tissues
stored in paraffin for up to nineteen years (15). The cells which stain posi
tively must be clearly identified as being immature forms, and must be evaluated
in context of the gross pathology. Whereas esterase activity alone may be useful
in ruling out neuroblastoma, rhabdomyosarcoma, and lymphosarcoma, the preservation
29
of accurate cytologic detail becomes increasingly important in ruling out an
inflammatory lesion. Similarly, esterase staining becomes less diagnostic in
situations where the lesion has become secondarily inflamed, with positively-
staining neutrophils present.
Electron Microscopy
Although formalin-fixed tissues are commonly thought to be unsatisfactory
for the evaluation of subcellular structures, in some controversial cases micro
scopy has revealed particular structures crucial to the diagnosis of certain neo
plasms, including granulocytic sarcoma (45, 46, 47, 48). Important features
sought to assist with the diagnosis include: 1) characteristic electron-dense
granules similar in morphology to the primary granules of early human neutrophils
(49) (these can be distinguished from early eosinophilic and basophilic granules),
2) dispersed heterochromatin, 3) prominent nucleoli, 4) granular endoplasmic
reticulum, 5) numerous large mitochondria, and 6) lack of monofilaments associated
with monocytes.
Ga Scintigraphy
As shown in the case of L. M., Ga scintigraphy may also be useful in the
diagnosis and follow-up of focal leukemic disease (50, 51). Milder and colleagues
(14) report positive Ga localization in four patients with granulocytic sarcoma
with all four lesions - two in the breast, one in the testes, one in the nasophasynx -
showing greatly decreased activity after effective chemotherapy. Similar lesions
were identified in another case report (51), although two 8 mm breast nodules were
apparently below the limits of scan sensitivity. Whereas Ga scintigraphy may offer
a means of discovering occult granulocytic sarcomata and following response to
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therapy, it must be noted that the mechanism of Ga uptake is not understood, and
the correlation between decreasing Ga uptake and cell death has never been proven.
Finally, mention must be made of two additional diagnostic tools, computerized
tomography which may prove useful in particular instances, and brain. scanning,
which has been recommended as a routine procedure for the identification of intra
cranial leukemic nodules (52).
LITERATURE REVIEW
Ophthalmologic Manifestations of Granulocytic Sarcoma
Intraocular leukemic disease has been observed to result in a wide variety
of manifestations depending upon the site and nature of the involvement (53, 54).
In particular, proptosis has been recognized as a "classical" clinical feature of
granulocytic sarcoma, but it appears that orbital involvement owes its frequent
citation more to its dramatic presentation than to its characteristic or diagnostic
association with the lesion. Liu and co-workers (27), in a report of twenty-three
cases of granulocytic sarcoma in 338 patients with granulocytic leukemia, noted
gross involvement of bone at autopsy in 21 patients, with lesions of the vertebrae
and sternum being twice as common as orbital lesions. Involvement of the orbit was
discovered in 25% of these cases, each associated with measurable exophthalmos.
Others report orbital involvement in up to 50% of all instances of granulocytic
sarcoma (55). As most large series of patients do not undergo full metastatic
work-up at the time of initial ophthalmologic evaluation, it is difficult to outline
the time course of bony involvement, but it appears that tumors of the orbit do not
occur distinctively earlier than at other sites. As a case in point, Brownstein et al .
(16) describe a fourteen year-old French Canadian youth evaluated for striking
proptosis and downward deviation of the left globe, with additional complaints of
malaise, anorexia, and lower back pain radiating to the left thigh and heel. Physical
examination revealed multiple neurologic deficits suggesting involvement of the left
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lumbosacral plexus, but a full diagnostic work-up including myelogram and intravenous
pyelogram was negative. Biopsy of the left orbital lesion revealed immature granulo
cytes and at autopsy ten weeks after admission, massive infiltration of the vertebral
column and para-aortic lymph nodes was found, corresponding to the patient's initial
complaints, although eluding detection.
Although isolated cases have been reported of orbital lesions without systemic
disease for up to one year (17), the series presented by Zimmerman and Font (15)
showed 60% of 33 patients with orbital granulocytic tumors to develop hematologic
evidence before or within two months of the onset of ophthalmologic signs and
symptoms, some with grossly visible evidence of diffuse tumor involvement. It is
noteworthy that 75% of these patients were in their first decade, with a median
age of seven years, a male predominance, and a particular geographic distribution.
Thus, although granulocytic sarcoma is an uncommon cause of unilateral expanding
lesions of the orbit for an unselected series (i.e. one leukemia-associated lesion in
230 consecutive cases in North America (56)), and similarly uncommon within a series
of North American children with acute granulocytic leukemia (no cases in a Mayo Clinic
series of 465 orbital tumors (57)), in an age-controlled group in Africa and Asia
the prevalence becomes significant. These, and children in the older North American
literature (58, 59, 60, 61, 62, 63, 64), have "classically" presented with proptosis,
although the lack of immediate medical care usually implied multiple tumor foci
and systemic spread on initial evaluation (65). For example, in an operative
evaluation of sixty cases of proptosis in African children less than sixteen years
of age (18), the eight reported cases of chloroma were second only to Burkitts
lymphoma, which is by far the commonest neoplastic cause of proptosis in African
children, with 28 cases in this series. In each of the eight children with orbital
granulocytic sarcoma, evidence of systemic disease was evident on initial bone marrow
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examination. Similarly, a study of thirteen African children with myeloid
leukemia (66) revealed eight to have granulocytic tumor deposits, six of which
involved the orbit. The most recent of a series of Turkish studies (17),
describes 56 children with acute myelomonocytic leukemia, twenty with orbital
granulocytic tumor deposits, all with bone marrow evidence of leukemia. Thus,
in Africa and Asia, where the leukemias of childhood are observed much less
frequently than in North America, granulocytic sarcoma is disproportionately
frequent whether compared with other forms of leukemia or other causes of proptosis
in childhood. It has been suggested that in these endemic areas (15) and even in
North America (64), granulocytic sarcoma must be suspected in the evaluation of
any orbital or facial tumor, indicating appropriate hematologic studies and
staining of the biopsy specimen for esterase activity.
CNS Manifestations of Granulocytic Sarcoma
Although central nervous system (CNS) involvement in acute leukemia often
presents non-specifically, with the stigmata of increased intracranial pressure,
a small yet significant subset of patients may present with paraplegia and/or
other focal neurologic signs corresponding to the presence of a grossly evident
mass lesion. Whereas spinal epidural leukemia has been a well documented clinical
entity (67, 68, 69, 70, 71, 72, 73), only recently have cases been reported of
intracranial (74, 75), and indeed, intraparenchymal (52, 76) granulocytic sarcoma.
These nodular lesions are distinct from the diffuse parenchymal infiltration
associated with arachnoidal infiltration with leukemic cells, and are generally
associated with leukostasis and focal hemorrhages.
In a pathologic examination of the CNS of 108 patients with acute leukemia,
Moore et al . (77) noted the incidence of leukemic infiltration of the dura to be
approximately 65%, with almost 8% of the cases exhibiting gross intracranial nodules
measuring between 0.5 and 2 cm in diameter. While there is a general correlation
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of extensive infiltration with a severe clinical syndrome, it is interesting that
the incidence of microscopic peridural infiltration was not significantly differ
ent in those patients with and without manifestations of meningeal leukemia.
Thus, symptomatology clearly lacks diagnostic sensitivity, as does lumbar puncture,
which reveals pleocytosis in the cerebrospinal fluid in less than 30% of cases of
CNS leukemia proven by autopsy (78). Since the chances of missing CNS leukemia
are therefore fairly high, even employing cytocentrifuge examination of the CSF,
it has been suggested that routine brain scan be performed, even in cases of proven
meningeal leukemia, to elucidate that subset of patients with associated intra
cranial nodules (52). Subsequently, computerized tomography and cerebral angio
graphy may further demonstrate the location and nature of the lesion in preparation
for surgical extirpation in appropriate cases (75).
Leukemic involvement of the spinal cord is not particularly rare, especially
in children, in whom leukemia has been reported to cause approximately 4% of
spinal cord tumors (79). Paraplegia most commonly results from ischemic necrosis
of the cord (72), with the pathogenesis generally involving direct compression by
the tumor mass, leukemic infiltration of the spinal cord, and vascular occlusion
due to the accumulation of leukemic cells. Opinion regarding the site of origin
of epidural deposits has varied. Possibilities include direct infiltration of
the dura, and extension through the intervertebral foramina from paravertebral
lymph nodes. Indeed, direct extension from within the involved vertebral body has
been suggested, as the tumor has been described to arise in the bone marrow and
traverse the Haversian canals to reach the subperiosteum (28). The tumor masses
are generally adherent to either the vertebral periosteum or the superficial layers
of the dura, with little involvement of the pia-arachnoid, explaining the lack of
sensitivity of CSF examination in these cases.
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In a review of 48 cases of paraplegia secondary to epidural leukemia,
Wilhyde and colleagues (72) found tumor at all levels of the spinal epidural
space, varying from discrete deposits localized to one vertebral segment to
sheets of tumor extending almost the full length of the spinal cord. The posterior
aspect of the epidural space was often the only area involved however, anterior
extension through intervertebral foramina with associated spinal root infiltration
was not uncommon. In approximately two-thirds of the 42 patients, symptoms of
spinal cord compression were the initial manifestations of leukemia, with back
and/or leg pain being particularly common. The development of paraplegia with double
incontinence generally followed rapidly, often within one week. For four patients,
paraplegia without antecedent back or leg pain was the initial evidence of leukemia.
In light of the previous discussion it is interesting that sixteen of the patients
in this series developed cranial nerve symptoms during their clinical course, with
discrete intracranial tumor nodules being found in nine patients. For two of these,
cranial nerve symptoms were the initial manifestations of leukemia.
The conclusions to be drawn from this series pertain to those patients who,
in the course of leukemic disease, will develop epidural granulocytic sarcoma
leading to paraplegia. Of note is the very early onset of symptomatology and rapid
progression to severe debilitation. This propensity for early involvement of the
spinal epidural space has been noted to be in distinct contrast to the reportedly
late (80) leukemic involvement of other parts of the central nervous system. In
this series, however, 40% of the patients exhibited early evidence of intracranial
involvement. Furthermore, as previously discussed (77), autopsy examination of a
majority of leukemia patients will reveal pathologic evidence of intracranial leukemic
infiltration in the absence of neurologic disturbances. Therefore, epidural tumors
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may be contrasted with intracranial infiltration insofar as they generally cause
overt symptomatology earlier in the course of disease, although the time course of
the development of the lesions may indeed be similar.
Soft Tissue Manifestations of Granulocytic Sarcoma
Although granulocytic tumors generally occur adjacent to osseous
structures, their invasiveness may be non-discriminating, their manifestations
protean (81). Soft tissue lesions may prove particularly difficult to evaluate
in the absence of systemic evidence of leukemia. The ovaries are a fairly common
site of involvement (82, 83, 84); as evidenced by the autopsy series of Liu and
colleagues (27), in which six of eight myeloblasts tumors in women involved the
ovaries. This pattern of infiltration is most common in women less than fifteen
years of age with acute myelocytic leukemia, and must be considered if such a
patient experiences pelvic symptomatology. Granulocytic tumors of the breast
(85, 86, 87), uterus (88), stomach, small bowel (19, 89, 90), skin (91), ribs (92),
and pleura and pericardium (40), have also been described.
Leukemic breast tumors appear to occur most commonly in women in the second
and third decades of life and, to our knowledge, no case has been reported in a
patient older than 49 years. The lesion may resemble a breast abscess or a
malignant neoplasm of the breast, most notably carcinoma. In one case report (85),
failure to fully evaluate the peripheral blood picture resulted in the performance
of a mastectomy on a patient with acute leukemia. Thus, careful preoperative
evaluation of the peripheral smear may in some cases forestall a radical surgical
procedure in favor of radiation therapy.
One interesting case report (94), describes a patient with acute myelocytic
leukemia and simultaneous development of granulocytic sarcomata in breast and
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ovarian tissue, coincident with menarche. This coincidence, the previously noted
preponderance of ovarian lesions in the peri-menarchal age group, and the
distinctively premenopausal age range for leukemic breast tumors, foster speculation
concerning the possible role of estrogens and progesterone in leukemogenesis. Al
though certain animal studies (95), have demonstrated a potential leukemogenic
effect of estrogens on some strains of mice, the mode of action is unknown. Presently,
no clear confirmatory evidence exists supporting leukemogenesis as a consequence
of endogenous or exogenous estrogens in humans.
CONCLUSION
In a significant percentage of cases, an opportunity for an early diagnosis
of granulocytic leukemia is missed as a consequence of a low index of suspicion
for granulocytic sarcoma and/or misinterpretation of the tumor biopsy specimen.
This situation would suggest a heightened clinical presentiment in particular
settings (i.e. "lymphomatous" skin nodules of uncertain origin, malignant breast
lesion of uncertain nature, proptosis in African children), possibly indicating
full hematologic evaluation in addition to tumor biopsy. Importantly, this
evaluation should include examination of the soft tissue specimen by an experienced
hematopathologist, with the use of cytochemical stains for naphthol AS-D chloracetate
esterase according to the method of Leder (13), to aid in the determination of
granulocytic differentiation.
As the identification of these lesions at an early stage becomes more common,
the issue of "preleukemic" therapy will become more important. Thus far, a fairly
non-aggressive course has been followed, centering upon the liberal use of radiation
therapy to the site of the lesion. In those patients with widespread tumor nodules,
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a variety of chemotherapeutic agents have been empirically employed, including
lymphoma protocols. Some of these agents, particularly steroids, have proven
efficacious in the short term, however, data from long term controlled studies
with any of these agents is unavailable. Institution of such a study might
prove valuable, particularly since the nature and efficacy of intensive therapy
of myelocytic leukemia has thus far mitigated against its use in those patients
with only localized disease. As systemic therapy improves, the need to correctly
identify these patients early will surely become more immediate.
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